Patent · US Active

Pyrimidinyl pyridazinone derivatives

US9062029B2 · kind B2 · utility

2Cited by

7References

4Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Oliver Schadt · Rodenbach, DE
Dieter Dorsch · Ober-Ramstadt, DE
Frank Stieber · Heidelberg, DE
Andree Blaukat · Heilbad Heiligenstadt, DE

Key dates

Filing date	Jan 7, 2014
Grant date	Jun 23, 2015
Priority date	—
Expiry date	Jan 7, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/2826
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds selected from the group according to Claim 1 are inhibitors of tyrosine kinases, in particular of Met kinase, and can be employed, inter alia, for the treatment of tumours.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.